DENTSPLY SIRONA Inc.
XRAY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.67 | 0.02 | -0.05 |
| FCF Yield | 7.29% | 3.02% | 5.36% | 4.23% |
| EV / EBITDA | -11.31 | 38.19 | -13.06 | 14.85 |
| Quality | ||||
| ROIC | -17.96% | -1.01% | -12.70% | 5.58% |
| Gross Margin | 51.62% | 52.61% | 54.23% | 55.47% |
| Cash Conversion Ratio | -0.51 | -2.86 | -0.54 | 1.60 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.11% | -2.14% | 5.51% | 1.70% |
| Free Cash Flow Growth | 23.25% | -38.04% | -28.54% | -8.36% |
| Safety | ||||
| Net Debt / EBITDA | -3.86 | 7.89 | -2.69 | 2.05 |
| Interest Coverage | -12.74 | -1.05 | -14.42 | 9.97 |
| Efficiency | ||||
| Inventory Turnover | 3.25 | 3.01 | 2.86 | 3.66 |
| Cash Conversion Cycle | 122.56 | 131.56 | 134.51 | 118.29 |